157 related articles for article (PubMed ID: 19852790)
1. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results.
Adams JB; Baral M; Geis E; Mitchell J; Ingram J; Hensley A; Zappia I; Newmark S; Gehn E; Rubin RA; Mitchell K; Bradstreet J; El-Dahr J
BMC Clin Pharmacol; 2009 Oct; 9():17. PubMed ID: 19852790
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A--medical results.
Adams JB; Baral M; Geis E; Mitchell J; Ingram J; Hensley A; Zappia I; Newmark S; Gehn E; Rubin RA; Mitchell K; Bradstreet J; El-Dahr J
BMC Clin Pharmacol; 2009 Oct; 9():16. PubMed ID: 19852789
[TBL] [Abstract][Full Text] [Related]
3. Chelation for autism spectrum disorder (ASD).
James S; Stevenson SW; Silove N; Williams K
Cochrane Database Syst Rev; 2015 May; (5):CD010766. PubMed ID: 26106752
[TBL] [Abstract][Full Text] [Related]
4. A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders.
Geier DA; Geier MR
Neuro Endocrinol Lett; 2006 Dec; 27(6):833-8. PubMed ID: 17187010
[TBL] [Abstract][Full Text] [Related]
5. 24-hour provoked urine excretion test for heavy metals in children with autism and typically developing controls, a pilot study.
Soden SE; Lowry JA; Garrison CB; Wasserman GS
Clin Toxicol (Phila); 2007; 45(5):476-81. PubMed ID: 17503250
[TBL] [Abstract][Full Text] [Related]
6. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
[TBL] [Abstract][Full Text] [Related]
7. The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning.
Glotzer DE
Drug Saf; 1993 Aug; 9(2):85-92. PubMed ID: 8397892
[TBL] [Abstract][Full Text] [Related]
8. Chelation for autism spectrum disorder (ASD).
James S; Stevenson SW; Silove N; Williams K
Cochrane Database Syst Rev; 2015 May; 5(5):CD010766. PubMed ID: 26114777
[TBL] [Abstract][Full Text] [Related]
9. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
[TBL] [Abstract][Full Text] [Related]
10. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
Bradberry S; Sheehan T; Vale A
QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
[TBL] [Abstract][Full Text] [Related]
11. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.
Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A
Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251
[TBL] [Abstract][Full Text] [Related]
12. Porphyrinuria in childhood autistic disorder: implications for environmental toxicity.
Nataf R; Skorupka C; Amet L; Lam A; Springbett A; Lathe R
Toxicol Appl Pharmacol; 2006 Jul; 214(2):99-108. PubMed ID: 16782144
[TBL] [Abstract][Full Text] [Related]
13. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.
Dietrich KN; Ware JH; Salganik M; Radcliffe J; Rogan WJ; Rhoads GG; Fay ME; Davoli CT; Denckla MB; Bornschein RL; Schwarz D; Dockery DW; Adubato S; Jones RL;
Pediatrics; 2004 Jul; 114(1):19-26. PubMed ID: 15231903
[TBL] [Abstract][Full Text] [Related]
14. Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity.
Miller AL
Altern Med Rev; 1998 Jun; 3(3):199-207. PubMed ID: 9630737
[TBL] [Abstract][Full Text] [Related]
15. Autism: a form of lead and mercury toxicity.
Yassa HA
Environ Toxicol Pharmacol; 2014 Nov; 38(3):1016-24. PubMed ID: 25461563
[TBL] [Abstract][Full Text] [Related]
16. DMSA.
Altern Med Rev; 2000 Jun; 5(3):264-7. PubMed ID: 10869106
[No Abstract] [Full Text] [Related]
17. Children with moderately elevated lead levels: is chelation with DMSA helpful?
O'Connor ME; Rich D
Clin Pediatr (Phila); 1999 Jun; 38(6):325-31. PubMed ID: 10378089
[TBL] [Abstract][Full Text] [Related]
18. Topical efficacy of dimercapto-chelating agents against lewisite-induced skin lesions in SKH-1 hairless mice.
Mouret S; Wartelle J; Emorine S; Bertoni M; Nguon N; Cléry-Barraud C; Dorandeu F; Boudry I
Toxicol Appl Pharmacol; 2013 Oct; 272(2):291-8. PubMed ID: 23806213
[TBL] [Abstract][Full Text] [Related]
19. A reply to Soden et al.: your data shows autistic children have higher levels of heavy metals.
DeSoto MC
Clin Toxicol (Phila); 2008 Dec; 46(10):1098; author reply 1098. PubMed ID: 18941966
[No Abstract] [Full Text] [Related]
20. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
Besunder JB; Anderson RL; Super DM
Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
